Albiglutide
Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
GSK · Phase 4 · Terminated · Enrollment 8
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.